Log In
Print this Print this

Firmagon, Gonax, degarelix (ASP3550)

  Manage Alerts
Collapse Summary General Information
Company Ferring Pharmaceuticals A/S
DescriptionGnRH/LHRH receptor antagonist
Molecular Target GnRH/LHRH receptor
Mechanism of ActionGnRH/LHRH receptor antagonist
Therapeutic ModalityPeptide
Latest Stage of DevelopmentMarketed
Standard IndicationProstate cancer
Indication DetailsTreat advanced hormone-dependent prostate cancer in patients with spinal metastases who are at risk of impending spinal cord compression; Treat advanced prostate cancer in patients with cardiovascular disease; Treat hormone-sensitive advanced prostate cancer; Treat prostate cancer
Regulatory Designation
PartnerAstellas Pharma Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today